Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Net Cash Flow: 2019-2024

Historic Net Cash Flow for Praxis Precision Medicines (PRAX) over the last 6 years, with Dec 2024 value amounting to $134.1 million.

  • Praxis Precision Medicines' Net Cash Flow fell 133.56% to -$7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.1 million, marking a year-over-year decrease of 128.30%. This contributed to the annual value of $134.1 million for FY2024, which is 581.09% up from last year.
  • Praxis Precision Medicines' Net Cash Flow amounted to $134.1 million in FY2024, which was up 581.09% from $19.7 million recorded in FY2023.
  • Over the past 5 years, Praxis Precision Medicines' Net Cash Flow peaked at $251.8 million during FY2020, and registered a low of -$157.5 million during FY2021.
  • For the 3-year period, Praxis Precision Medicines' Net Cash Flow averaged around $25.4 million, with its median value being $19.7 million (2023).
  • Its Net Cash Flow has fluctuated over the past 5 years, first surged by 837.25% in 2020, then crashed by 162.55% in 2021.
  • Yearly analysis of 5 years shows Praxis Precision Medicines' Net Cash Flow stood at $251.8 million in 2020, then slumped by 162.55% to -$157.5 million in 2021, then spiked by 50.67% to -$77.7 million in 2022, then soared by 125.34% to $19.7 million in 2023, then surged by 581.09% to $134.1 million in 2024.